May 29, 2017 8:20 PM ET

Pharmaceuticals

Company Overview of Gadea Grupo Farmacéutico, S.L.U.

Company Overview

Gadea Grupo Farmacéutico, S.L.U., a holding company, operating through its subsidiary, develops and manufactures active pharmaceutical ingredients (API) and related products. The company offers general APIs, steroids, sex hormones, sterile filtration products, and others; and aseptic filling of vials, prefilled syringes, eye drops, suspensions and freeze drying products, bulk APIs, and vials. It also provides steroid based drugs for the therapeutic class of sex hormones and regulators of the gonadal function; and steroid based drugs corresponding to the therapeutic class of adrenal corticosteroids. In addition, the company offers contract development and manufacturing services, and licensing...

Parque Tecnologico

Parcela 113

Boecillo

Valladolid,  47151

Spain

Founded in 1991

Phone:

34 983 54 80 72

Fax:

34 983 54 81 13

Key Executives for Gadea Grupo Farmacéutico, S.L.U.

Gadea Grupo Farmacéutico, S.L.U. does not have any Key Executives recorded.

Gadea Grupo Farmacéutico, S.L.U. Key Developments

Albany Molecular Research Inc., Gadea Grupo Farmacéutico Sl - M&A Call

To discuss acquisition of all the outstanding shares of Gadea Pharmaceutical Group by AMRI

Gadea Pharmaceutical Group Provides Earnings Guidance for 2015

Gadea Pharmaceutical Group provided earnings guidance for 2015. AMRI announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group. Gadea is expected to continue to operate independently within AMRI's API segment. On a stand-alone basis, Gadea's forecasted full year of 2015 revenue is estimated to be between $80 million and $90 million, with adjusted EBITDA of between $18 million and $20 million, implying a purchase price multiple of approximately 9 times 2015 adjusted EBITDA at the midpoint of the range. Adjusted EBITDA excludes any deal related costs or purchase accounting impacts.

Similar Private Companies By Industry

Company Name Region
Ability Pharmaceuticals, S.L. Europe
Activery Biotech SL Europe
Aelix Therapeutics SL Europe
AlbaJuna Therapeutics SL Europe
Alcaliber S.A. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gadea Grupo Farmacéutico, S.L.U., please visit www.gadea.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.